Immunome

+$0.07 (+0.46%) As of 2:31 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunome and other ETFs, options, and stocks.

About IMNM

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It focuses on oncology and infectious disease areas.

CEO
Purnanand D. Sarma
Employees
23
Headquarters
Exton, Pennsylvania
Founded
2006

IMNM Key Statistics

Market Cap
209.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.33M
High Today
$15.51
Low Today
$14.87
Open Price
$15.42
Volume
28.91K
52 Week High
$63.78
52 Week Low
$9.28

IMNM Earnings

-$7.52
-$5.01
-$2.51
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure